InsidersTradesSigma
Discover the full directors' dealings record of Pharma Mar, S.A., a listed equity based in Spain. Shares are quoted on ES ES, under the authority of CNMV. Operating in the Healthcare & Pharma sector, Pharma Mar, S.A. has recorded 57 public disclosures. Market capitalisation: €1.7bn. The latest transaction was filed on 22 April 2026 — Purchase. Among the most active insiders: MONTSERRAT ANDRADE DETRELL. Every trade is openly available.
0 of 0 declarations
PHARMA MAR, S.A. is a Spanish biopharmaceutical company focused on the research and development of cancer treatments. It is listed on the Spanish stock market, XMAD.